A neuroscientist by training, Matthias co-leads our work on R&D with pharmaceutical and medical products companies in Europe, the Middle East, and Africa. Since joining McKinsey in 2002, he has supported pharma clients not only in the EU and US, but also in Asia as they take on strategic challenges of driving productivity, pipeline value creation, and gaining market access and negotiating the interface between product development and commercialization.
Matthias has served clients on holistic R&D performance transformations, early clinical product strategies, and functional-excellence and capability building initiatives in various areas of R&D, such as translational medicine. Recently, Matthias helped redesign a clinical strategy for critical pipeline projects to maximize the potential of new chemical compounds while accelerating the development timelines. He also helped to build medical-affairs organizations that provide optimal support for such compounds, in collaboration with R&D and Commercial teams.
Matthias is one of the co-founders of McKinsey’s cross-industry Medical Affairs Forum.
“Escaping the sword of Damocles: Toward a new future for pharmaceutical R&D,” McKinsey, 2012 (Request a hard copy, full PDF, or iPad version of the 2012 R&D compendium)
“Value-Driven Drug Development—Unlocking the Value of Your Pipeline” (PDF–293 KB), McKinsey, 2011
“The Future of Drug Development: Advancing Clinical Trial Design,” Nature Reviews Drug Discovery, December 2009
|Ruhr University Bochum, Germany and Center for Molecular Neurobiology, Hamburg
||PhD, biochemistry with a focus on neuroscience